SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-189023
Filing Date
2021-06-11
Accepted
2021-06-11 17:18:37
Documents
12
Period of Report
2021-06-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d153879d8k.htm   iXBRL 8-K 41614
  Complete submission text file 0001193125-21-189023.txt   162379

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20210611.xsd EX-101.SCH 3078
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20210611_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20210611_pre.xml EX-101.PRE 10958
5 EXTRACTED XBRL INSTANCE DOCUMENT d153879d8k_htm.xml XML 3234
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 211012314
SIC: 2836 Biological Products, (No Diagnostic Substances)